Pesquisa | Biblioteca Virtual em Saúde

1.

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study.

Lorigan, P; Marples, M; Harries, M; Wagstaff, J; Dalgleish, A G; Osborne, R; Maraveyas, A; Nicholson, S; Davidson, N; Wang, Q; Pericleous, L; Bapat, U; Middleton, M R.

Br J Dermatol ; 170(1): 87-95, 2014 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-23855404

2.

Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.

Henry, J Y; Lu, L; Adams, M; Meyer, B; Bartlett, J B; Dalgleish, A G; Galustian, C.

Prostate ; 72(8): 856-67, 2012 Jun 01.

Artigo em Inglês | MEDLINE | ID: mdl-21968939

3.

Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis.

Liu, W M; Dennis, J L; Gravett, A M; Chanthirakumar, C; Kaminska, E; Coulton, G; Fowler, D W; Bodman-Smith, M; Dalgleish, A G.

Br J Cancer ; 106(5): 896-903, 2012 Feb 28.

Artigo em Inglês | MEDLINE | ID: mdl-22294186

4.

Supernatants from lymphocytes stimulated with Bacillus Calmette-Guerin can modify the antigenicity of tumours and stimulate allogeneic T-cell responses.

Liu, W M; Fowler, D W; Gravett, A M; Smith, P; Dalgleish, A G.

Br J Cancer ; 105(5): 687-93, 2011 Aug 23.

Artigo em Inglês | MEDLINE | ID: mdl-21829193

5.

Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells.

Ioannou, N; Dalgleish, A G; Seddon, A M; Mackintosh, D; Guertler, U; Solca, F; Modjtahedi, H.

Br J Cancer ; 105(10): 1554-62, 2011 Nov 08.

Artigo em Inglês | MEDLINE | ID: mdl-21970876

6.

Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells.

Smith, P L; Yogaratnam, Y; Samad, M; Kasow, S; Dalgleish, A G.

Clin Transl Oncol ; 23(1): 110-121, 2021 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-32661823

7.

Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses.

Liu, W M; Fowler, D W; Smith, P; Dalgleish, A G.

Br J Cancer ; 102(1): 115-23, 2010 Jan 05.

Artigo em Inglês | MEDLINE | ID: mdl-19997099

8.

Investigator-initiated trials of targeted oncology agents: why independent research is at risk?

Bergmann, L; Berns, B; Dalgleish, A G; von Euler, M; Hecht, T T; Lappin, G L; Reed, N; Palmeri, S; Smyth, J; Embacher-Aichorn, S; Zwierzina, H.

Ann Oncol ; 21(8): 1573-1578, 2010 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-20133383

9.

The effect of colorectal cancer upon host peripheral immune cell function.

Evans, C F M; Galustian, C; Bodman-Smith, M; Dalgleish, A G; Kumar, D.

Colorectal Dis ; 12(6): 561-9, 2010 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-19250260

10.

Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs).

Liu, W M; Henry, J Y; Meyer, B; Bartlett, J B; Dalgleish, A G; Galustian, C.

Br J Cancer ; 101(5): 803-12, 2009 Sep 01.

Artigo em Inglês | MEDLINE | ID: mdl-19638977

11.

Epitopes of the CD4 antigen and HIV infection.

Sattentau, Q J; Dalgleish, A G; Weiss, R A; Beverley, P C.

Science ; 234(4780): 1120-3, 1986 Nov 28.

Artigo em Inglês | MEDLINE | ID: mdl-2430333

12.

How immunotherapy can enhance the response to other modalities and improve outcome and quality of life.

Liu, W M; Meyer, B; Dalgleish, A G.

J BUON ; 14 Suppl 1: S103-9, 2009 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-19785052

13.

Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma.

Green, D S; Dalgleish, A G; Belonwu, N; Fischer, M D; Bodman-Smith, M D.

Br J Dermatol ; 159(3): 606-14, 2008 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-18616776

14.

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

Gravett, A M; Trautwein, N; Stevanovic, S; Dalgleish, A G; Copier, J.

Oncoimmunology ; 7(6): e1438107, 2018.

Artigo em Inglês | MEDLINE | ID: mdl-29930882

15.

Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule.

Cottrez, F; Manca, F; Dalgleish, A G; Arenzana-Seisdedos, F; Capron, A; Groux, H.

J Clin Invest ; 99(2): 257-66, 1997 Jan 15.

Artigo em Inglês | MEDLINE | ID: mdl-9005994

16.

Immunobiological aspects of HIV treatment.

Dalgleish, A G.

Curr Opin Immunol ; 5(4): 608-14, 1993 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-8105805

17.

HIV types and testing.

Dalgleish, A G.

Curr Opin Immunol ; 3(4): 543-6, 1991 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-1755980

18.

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies.

Sharma, R A; Steward, W P; Daines, C A; Knight, R D; O'Byrne, K J; Dalgleish, A G.

Eur J Cancer ; 42(14): 2318-25, 2006 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-16899362

19.

Review article: immune suppression and colorectal cancer.

Evans, C; Dalgleish, A G; Kumar, D.

Aliment Pharmacol Ther ; 24(8): 1163-77, 2006 Oct 15.

Artigo em Inglês | MEDLINE | ID: mdl-17014575

20.

Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells

Smith, P. L; Yogaratnam, Y; Samad, M; Kasow, S; Dalgleish, A. G.

Clin. transl. oncol. (Print) ; 23(1): 110-121, ene. 2021. graf

Artigo em Inglês | IBECS (Espanha) | ID: ibc-220456

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar: